Case Study: Insight Investment achieves flexible OTC scalability with Xenomorph TimeScape

Insight Investment - Customer Case Study

Insight Investment, a UK asset manager with more than £119 billion in assets under management, needed to rapidly merge the IT systems and business processes of three organizations while building an end-to-end derivatives platform that could support any type of OTC instrument and scale for future growth. To meet these goals, Insight turned to Xenomorph and its TimeScape platform.

Xenomorph implemented TimeScape as a centralized, flexible OTC data and pricing platform with support for proprietary and third-party models, enabling Insight to manage all reference, market, and pricing data in one place. The result was faster and more controlled OTC processing, consistent access to pricing analytics, and the ability to add new instruments and models without vendor involvement, helping Insight support 25 product flavors and tens of thousands of market instruments.

Insight Investment

Gareth Exell

Head of IT Strategy